Long‐term follow‐up of dose‐dense brentuximab vedotin, ifosfamide, carboplatin and etoposide in second‐line treatment of relapsed/refractory classical Hodgkin lymphoma
British Journal of Haematology · 2025
DOI: 10.1111/bjh.70052 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Ryan C Lynch und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology Oncology, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Hodgkin Disease, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 19 Literaturangaben. Gefördert von: Seagen, NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology Oncology, University of Washington, Seattle, Washington, USA.
- Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
ORCID-Profile: Ryan C Lynch, Andrew J Cowan, Chaitra S Ujjani
Förderung
- Seagen
- NCI NIH HHS
Zitieren
APA
Lynch, R. C., Cassaday, R. D., Smith, S. D., Cowan, A. J., Warren, E. H., Shadman, M. S., Till, B. G., Ujjani, C. S., Morris, K., Rasmussen, H., Voutsinas, J., & Gopal, A. K. (2025). Long‐term follow‐up of dose‐dense brentuximab vedotin, ifosfamide, carboplatin and etoposide in second‐line treatment of relapsed/refractory classical Hodgkin lymphoma. British Journal of Haematology. https://doi.org/10.1111/bjh.70052
Vancouver
Lynch RC, Cassaday RD, Smith SD, Cowan AJ, Warren EH, Shadman MS, et al. Long‐term follow‐up of dose‐dense brentuximab vedotin, ifosfamide, carboplatin and etoposide in second‐line treatment of relapsed/refractory classical Hodgkin lymphoma. British Journal of Haematology. 2025. doi:10.1111/bjh.70052
BibTeX
@article{Lynch2025,
author = {Lynch, Ryan C and Cassaday, Ryan D and Smith, Stephen D and Cowan, Andrew J and Warren, Edus H and Shadman, Mazyar S and Till, Brian G and Ujjani, Chaitra S and Morris, Karolyn and Rasmussen, Heather and Voutsinas, Jenna and Gopal, Ajay K},
title = {Long‐term follow‐up of dose‐dense brentuximab vedotin, ifosfamide, carboplatin and etoposide in second‐line treatment of relapsed/refractory classical Hodgkin lymphoma},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.70052}
}
EUVIMED